Lazertinib, a Third Generation EGFR-TKI, in Patients with EGFR-TKI-Resistant NSCLC: Updated Results of a Phase I/II Study

  • Cho, B. C.
  • Han, J.
  • Kim, S.
  • Lee, K.
  • Kim, D.
  • 외 17명
Citations

WEB OF SCIENCE

1

키워드

LazertinibT790M3rd generation EGFR TKI
제목
Lazertinib, a Third Generation EGFR-TKI, in Patients with EGFR-TKI-Resistant NSCLC: Updated Results of a Phase I/II Study
저자
Cho, B. C.Han, J.Kim, S.Lee, K.Kim, D.Lee, Y.Lee, G.Lee, J.Cho, E. K.Kim, J.Lee, S. S.Min, Y. J.Kim, J.Shin, S. W.Kim, H. R.Hong, M. H.Ahn, J. S.Kang, S.Kim, S.Jang, S. B.Choi, S.Ahn, M.
DOI
10.1016/j.jtho.2018.08.544
발행일
2018-10
유형
Meeting Abstract
저널명
Journal of Thoracic Oncology
13
10
페이지
S453 ~ S453